Cigna Group CI
272.01
6.51
2.45%
as of 25 Sep
- Market cap
- $69.9B
- P/E
- 11.3×
Follow CI
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cigna Group (CI) Shares outstanding
Cigna Group's shares outstanding at the end of fiscal 2025 was $268.6M, down 5.17% from $283.2M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $264.0M. Over the past ten years it has ranged from $250.2M (fiscal 2018) to $379.8M (fiscal 2019); the current reading is higher than 45% of that period. Cigna Group ranks 6th of 12 Healthcare Plans companies by shares outstanding.
Shares outstanding, annual
Annual
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $268.6M | (5.17%) |
| FY2024 | $283.2M | (4.60%) |
| FY2023 | $296.9M | (5.17%) |
| FY2022 | $313.1M | (8.18%) |
| FY2021 | $341.0M | (7.44%) |
| FY2020 | $368.4M | (3.01%) |
| FY2019 | $379.8M | 51.79% |
| FY2018 | $250.2M | (1.90%) |
| FY2017 | $255.1M | (1.76%) |
| FY2016 | $259.6M | (0.36%) |
Quarterly
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $264.0M | (0.02%) |
| Mar 2026 | $264.0M | (1.69%) |
| Dec 2025 | $268.6M | 0.39% |
| Sep 2025 | $267.5M | (0.23%) |
| 42 more quarters | Free account |
Against its own ten years
Low $250.2M
High $379.8M
Ten-year median
$283.2M
Current reading's percentile
45
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| CVS CVS Health Corporation compare | $1.3B |
| UNH UnitedHealth Group Incorporated compare | $906.0M |
| CLOV Clover Health Investments, Corp. compare | $545.4M |
| CNC Centene Corporation compare | $497.6M |
| OSCR Oscar Health, Inc. compare | $333.4M |
| CI Cigna Group | $264.0M |
| ELV Elevance Health, Inc. compare | $217.9M |
| HUM Humana Inc. compare | $121.1M |
| MOH Molina Healthcare, Inc compare | $51.3M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on CI
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- The full statement